ORS whistleblower calls for joint-regulatory protocol to curb misleading brand sales
Delivering a special address at the 2nd edition of ETHealthworld NutriWell Conclave, Dr. Shivranjani Santosh said, loop…
Delivering a special address at the 2nd edition of ETHealthworld NutriWell Conclave, Dr. Shivranjani Santosh said, loop…
The investment will be used to support the next phase of growth, including expansion into new markets and strengthening…
Studies have shown evidence that supports targeting the body's circadian clock for mitigating and treating cancer b…
The energy-to-retail conglomerate is leveraging Strand Life Sciences for its entry into the emerging areas of specialis…
Post the open offer, IHH's shareholding stands at 31.17 per cent and 62.73 per cent in Fortis Healthcare and Malar …
A year-wise analysis highlights steady growth with intermittent churn. In 2021, CGHS empanelled 266 hospitals, while 22…
The trial, titled Intermittent PARP Inhibitor Regimen in Ovarian Cancer (IPIROC), will evaluate whether an intermittent…